FDA and CDC OK resuming J&J COVID-19 shots paused over rare clot concerns

After reviewing safety data on rare blood clots linked to the Johnson & Johnson COVID-19 vaccine, federal regulators said vaccinations can resume immediately in people 18 and older. The U.S. Food and Drug Administration and the U.S. Centers for Disease Control and Prevention made the ruling April 23 following a meeting of CDC’s Advisory Committee on Immunization Practices about the vaccine, made by Janssen, J&J’s vaccine division.
Read more...

;